Imerys Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Imerys de 112% y 3.6% por año respectivamente. Se prevé que el BPA crezca en un 1.7% al año. Se espera que la rentabilidad financiera sea de 11% en 3 años.

Información clave

112.0%

Tasa de crecimiento de los beneficios

1.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Basic Materials	27.1%
Tasa de crecimiento de los ingresos	3.6%
Rentabilidad financiera futura	11.0%
Cobertura de analistas	Low
Última actualización	25 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

LSE:0NPX - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	3,878	346	202	N/A	3
12/31/2025	3,689	312	179	N/A	4
12/31/2024	3,656	-53	155	N/A	4
9/30/2024	3,668	-275	N/A	N/A	N/A
6/30/2024	3,731	48	159	549	N/A
3/31/2024	3,723	15	N/A	N/A	N/A
12/31/2023	3,794	8	205	603	N/A
9/30/2023	3,924	189	N/A	N/A	N/A
6/30/2023	4,122	126	120	544	N/A
3/31/2023	4,266	177	N/A	N/A	N/A
12/31/2022	4,282	173	62	452	N/A
9/30/2022	4,904	191	N/A	N/A	N/A
6/30/2022	3,648	187	145	534	N/A
3/31/2022	4,535	241	N/A	N/A	N/A
12/31/2021	3,665	181	182	543	N/A
9/30/2021	4,249	151	N/A	N/A	N/A
6/30/2021	4,057	115	233	502	N/A
3/31/2021	3,829	58	N/A	N/A	N/A
12/31/2020	3,799	30	284	538	N/A
9/30/2020	3,822	56	N/A	N/A	N/A
6/30/2020	3,991	82	304	609	N/A
3/31/2020	4,259	98	N/A	N/A	N/A
12/31/2019	4,355	121	203	516	N/A
9/30/2019	4,485	-35	N/A	N/A	N/A
6/30/2019	4,543	-294	189	473	N/A
3/31/2019	4,584	-235	N/A	N/A	N/A
12/31/2018	4,590	-228	280	616	N/A
9/30/2018	4,356	0	N/A	N/A	N/A
6/30/2018	4,545	324	N/A	688	N/A
3/31/2018	4,693	381	N/A	N/A	N/A
12/31/2017	4,299	301	N/A	622	N/A
9/30/2017	4,432	342	N/A	N/A	N/A
6/30/2017	4,133	273	N/A	614	N/A
3/31/2017	4,240	299	N/A	N/A	N/A
12/31/2016	4,165	293	N/A	634	N/A
9/30/2016	4,129	69	N/A	N/A	N/A
6/30/2016	4,126	81	N/A	557	N/A
3/31/2016	4,151	72	N/A	N/A	N/A
12/31/2015	4,087	68	N/A	545	N/A
9/30/2015	3,991	284	N/A	N/A	N/A
6/30/2015	3,908	285	N/A	480	N/A
3/31/2015	3,758	263	N/A	N/A	N/A
12/31/2014	3,688	272	N/A	417	N/A
9/30/2014	3,673	249	N/A	N/A	N/A
6/30/2014	3,655	245	N/A	448	N/A
3/31/2014	3,672	250	N/A	N/A	N/A
12/31/2013	3,698	242	N/A	463	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que 0NPX sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.1%).

Beneficios vs. Mercado: Se prevé que 0NPX sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que 0NPX sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.6% al año) de 0NPX crezcan más rápidamente que los del mercado UK (3.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.6% al año) de 0NPX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 0NPX sea baja dentro de 3 años (11%).

Imerys Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Third quarter 2024 earnings released

Now 23% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Second quarter 2024 earnings released

Upcoming dividend of €1.35 per share

Imerys S.A. to Report Q2, 2024 Results on Jul 29, 2024

First quarter 2024 earnings released

Imerys Enters into Exclusive Negotiations for the Sale of its Assets Serving the Paper Market

Now 21% overvalued after recent price rise

New minor risk - Financial position

Full year 2023 earnings released: EPS: €0.076 (vs €2.04 in FY 2022)

Now 25% overvalued after recent price rise

Mytilineos S.A. (ATSE:MYTIL) acquired IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK).

Investor sentiment improves as stock rises 22%

Now 33% overvalued after recent price rise

Imerys S.A. to Report Q1, 2024 Results on Apr 30, 2024

Imerys S.A. to Report Fiscal Year 2023 Results on Feb 21, 2024

Mytilineos S.A. (ATSE:MYTIL) signed an agreement to acquire IMERYS Greece Bauxite from Imerys S.A. (ENXTPA:NK) for €10 million.

Mytilineos is in Advanced Negotiations to Acquire Imerys Bauxite Greece

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Upcoming dividend of €3.85 per share at 4.3% yield

First quarter 2023 earnings released: EPS: €0.73 (vs €0.86 in 1Q 2022)

Full year 2022 earnings released: EPS: €1.89 (vs €2.84 in FY 2021)

Imerys S.A. to Report Q1, 2023 Results on May 02, 2023

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) in a transaction valued at approximately €930 million.

Platinum Equity, LLC acquired High Temperature Solutions Business of Imerys S.A. from Imerys S.A. (ENXTPA:NK) for approximately €930 million.

High number of new directors

Third quarter 2022 earnings released

Imerys S.A. to Report Fiscal Year 2022 Results on Feb 16, 2023

Platinum Equity Advisors, LLC acquired CALDERYS France S.A.S. from Imerys S.A. (ENXTPA:NK).

Imerys S.A. Announces Executive Appointments

CIMBAR Performance Minerals, Inc. acquired Sahuarita Arizona operation of Imerys.

Imerys Introduces ImerShield Solutions

Second quarter 2022 earnings released: EPS: €1.41 (vs €0.82 in 2Q 2021)

High number of new directors

Upcoming dividend of €1.55 per share

Northern Graphite Corporation (TSXV:NGC) completed the acquisition of Okanjande graphite deposit in Namibia from Imerys S.A. (ENXTPA:NK).

First quarter 2022 earnings released: EPS: €0.86 (vs €0.85 in 1Q 2021)

Investor sentiment improved over the past week

Now 21% undervalued

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: EPS €0.89 (vs €0.48 in 3Q 2020)

Third quarter 2021 earnings released: EPS €0.89 (vs €0.48 in 3Q 2020)

Imerys S.A. (ENXTPA:NK) commences an Equity Buyback Plan for 8,494,095 shares, representing 10% of its issued share capital, under the authorization approved on May 10, 2021.

Second quarter 2021 earnings released: EPS €0.82 (vs €0.16 in 2Q 2020)

Upcoming dividend of €1.15 per share

First quarter 2021 earnings released: EPS €0.85 (vs €0.56 in 1Q 2020)

New 90-day high: €45.08

Revenue beats expectations

Full year 2020 earnings released: EPS €0.37 (vs €1.53 in FY 2019)

Imerys S.A. to Report Fiscal Year 2020 Results on Feb 18, 2021

New 90-day high: €39.03

New 90-day high: €37.82

New 90-day high: €35.12

Market bids up stock over the past week

Market bids up stock over the past week

Imerys S.A. (ENXTPA:NK) acquired Sunward Refractories Co., Ltd.

Revenue misses expectations

New 90-day low: €29.96

Imerys USA Inc. completed the acquisition of Kentucky-Tennessee Clay Co. from Hecla Mining.

Imerys S.A. to Report Q1, 2021 Results on Apr 29, 2021

Imerys S.A. (ENXTPA:NK) signed an agreement to acquire 60% stake in Haznedar Refrakter Sanayii A.S.

New 90-day high - €35.40

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento